We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02759900
Recruitment Status : Recruiting
First Posted : May 3, 2016
Last Update Posted : April 12, 2022
Sponsor:
Information provided by (Responsible Party):
The Skin Center Dermatology Group

Brief Summary:
This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders

Condition or disease Intervention/treatment Phase
Actinic Keratosis Acne/Rosacea Verruca Plana Tinea Molluscum Contagiosum Bowen's Disease Warts Device: Non-thermal, atmospheric plasma to treat skin lesions and acne Device: Indirect non-thermal, atmospheric plasma to treat hair loss and acne Not Applicable

Detailed Description:
The study uses non-thermal atmospheric pressure plasma to treat target conditions. The patients are monitored at set intervals for efficacy and adverse effects using investigator's assessment and imaging techniques

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
Actual Study Start Date : January 2016
Estimated Primary Completion Date : March 2024
Estimated Study Completion Date : January 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Skin Conditions

Arm Intervention/treatment
Experimental: Non-thermal atmospheric plasma treatment
Device treatment
Device: Non-thermal, atmospheric plasma to treat skin lesions and acne
Non-thermal, atmospheric plasma treatment of affected area or lesions using a nanosecond dielectric barrier discharge plasma device

Experimental: Indirect non-thermal atmospheric plasma treatment
A compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound
Device: Indirect non-thermal, atmospheric plasma to treat hair loss and acne
A compound of non-thermal, atmospheric plasma and medium is delivered to or generated at the target area. Plasma is generated using either microsecond dielectric barrier discharge plasma device or PiezoBrush (a helium jet plasma). The medium is an aqueous alcohol solution




Primary Outcome Measures :
  1. Clinical improvement [ Time Frame: 1-12 months ]
    The outcome is the presence or lack of clinical improvement in the investigator's global assessment and reviewing photo-documentation as well as reflectance confocal microscopy study investigator's global assessment and reviewing photo-documentation



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnoses of target conditions
  • ability to complete study protocol

Exclusion Criteria:

  • based on specific condition

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02759900


Locations
Layout table for location information
United States, New York
The Skin Center Dermatology Group Recruiting
New City, New York, United States, 10956
Contact: Peter C Friedman, MD, PhD    845-352-0500    pbc9@columbia.edu   
Sponsors and Collaborators
The Skin Center Dermatology Group
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: The Skin Center Dermatology Group
ClinicalTrials.gov Identifier: NCT02759900    
Other Study ID Numbers: 20130084
First Posted: May 3, 2016    Key Record Dates
Last Update Posted: April 12, 2022
Last Verified: April 2022
Additional relevant MeSH terms:
Layout table for MeSH terms
Molluscum Contagiosum
Keratosis, Actinic
Bowen's Disease
Keratosis
Rosacea
Skin Diseases
Precancerous Conditions
Neoplasms
DNA Virus Infections
Virus Diseases
Infections
Skin Diseases, Viral
Skin Diseases, Infectious
Poxviridae Infections
Carcinoma, Squamous Cell
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms, Squamous Cell